TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $684,000 | +564.1% | 100,000 | +793.3% | 0.02% | +466.7% |
| Q1 2017 | $103,000 | +39.2% | 11,194 | -39.2% | 0.00% | +50.0% |
| Q4 2016 | $74,000 | +19.4% | 18,425 | +13.2% | 0.00% | +100.0% |
| Q3 2016 | $62,000 | -4.6% | 16,277 | +7.4% | 0.00% | 0.0% |
| Q2 2016 | $65,000 | -68.3% | 15,157 | -65.8% | 0.00% | -80.0% |
| Q1 2016 | $205,000 | -9.3% | 44,367 | +97.2% | 0.01% | -16.7% |
| Q4 2015 | $226,000 | -68.0% | 22,500 | -76.2% | 0.01% | -75.0% |
| Q3 2015 | $706,000 | +423.0% | 94,600 | +846.0% | 0.02% | +242.9% |
| Q4 2013 | $135,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |